Impact of long-term oral iron supplementation in breast-fed infants

Area of Science:

• Pediatric Nutrition
• Iron Metabolism
• Infant Health

Background:

• Exclusive breastfeeding is recommended for infants, but iron deficiency can be a concern.
• Oral iron supplementation is a common intervention, but its benefits and risks require careful evaluation.
• Infant growth and morbidity are critical indicators of nutritional status.

Purpose of the Study:

• To evaluate the benefits of oral iron supplements on infant growth.
• To assess potential hazards associated with oral iron supplementation in infants.
• To determine the impact of iron supplementation on infant morbidity.

Main Methods:

• A randomized controlled trial involving 248 exclusively breast-fed infants aged 4-6 months.
• Infants were divided into a treatment group receiving iron-containing multivitamins and a control group receiving placebo.
• Subgroup analysis included well-nourished and malnourished infants, stratified by iron status, with assessments at 6 and 12 months, including morbidity data.

Main Results:

• Oral iron supplementation led to significantly better weight and length gain after 6 months, especially in anemic, malnourished infants.
• Morbidity risk (diarrhea, fever) was higher in malnourished infants, independent of iron therapy.
• No significant increase in morbidity was observed in well-nourished, non-anemic infants receiving iron compared to placebo.

Conclusions:

• Oral iron supplementation enhances growth velocity in exclusively breast-fed infants, particularly those who are malnourished and anemic.
• The positive effects on growth outweigh potential morbidity risks in iron-depleted infants.
• Iron supplementation appears safe and beneficial for growth in this vulnerable infant population.